Prescription drugs provide therapeutic value to millions of Americans. At the same time, rates of prescription drug abuse and overdose deaths are skyrocketing. The annual number of fatal drug overdoses in the United States now surpasses those of motor vehicle deaths. The Center supports innovative research and public advocacy to help stem this epidemic.
Release of Opioid Report October 2017
On October 30, 2017, the Center for Drug Safety and Effectiveness, in partnership with the Center for Injury Research & Policy and the Clinton Foundation, co-hosted a forum focused on elevating high-impact solutions to the nation’s opioid epidemic.
In this third Johns Hopkins-hosted town hall aimed at addressing the opioid epidemic, speakers, panelists, and thought leaders representing diverse stakeholders affected by the crisis considered critical components needed to reduce the injury and death rates nationwide. Evidence-based recommendations that reflect the most current science were the focus, and translating that evidence to action was the goal. The event coincided with the release of a comprehensive report containing recommendations to diverse stakeholder groups regarding policy solutions to address the epidemic.
View the event page and official report, “The Prescription Opioid Epidemic: From Evidence to Impact.”
Video of the October 2017 Forum
Release of Opioid Report November 2015
In November 2015, the Center for Drug Safety and Effectiveness, in partnership with the Center for Injury Research & Policy and the Clinton Foundation, released a comprehensive report focused on providing concrete, evidence-based solutions to the opioid epidemic. View the event page and official report, “The Prescription Opioid Epidemic: An Evidence-Based Approach.”
The event, co-hosted by the Clinton Health Matters Initiative (CHMI), built on momentum and progress from the 2014 town hall, and convened thought leaders from across industries and sectors to discuss evidence-based solutions designed to address the epidemic from a holistic approach. Speakers and panelists presented recommendations from cross-disciplinary work groups focused on areas ranging from community-based prevention strategies to addiction treatment initiatives. Those in attendance had the opportunity to engage in direct dialogue with each other as well as working-group leads through facilitated discussion modules.
Previously, in May 2014, a diverse group of experts - including clinicians, researchers, government officials, injury prevention professionals, law enforcement leaders, pharmaceutical manufacturers and distributors, lawyers, health insurers and patient representatives - gathered at the Johns Hopkins Bloomberg School of Public Health. The group convened to review what is known about the prescription opioid epidemic; to identify strategies for reversing the alarming trends in injuries and deaths from these drugs; and to make recommendations for action. In the months that followed, work groups reviewed the available evidence.
Highlights from May 2014 Townhall (9:41)